|
 |
Luisa Giaccone dottoressa |
Luisa Giacone frequenta l'Istituto O. Romero alla fine degli anni '80 (1988-1992)
Il suo corso di studi è definito PACLE (Perito Aziendale e corrispondente in lingue estere) una "sperimentazione" del classico corso di Ragioneria che orientava alle professioni giuridiche ed economiche o ai corsi di Laurea nelle stesse discipline.
Il PACLE aveva una forte caratterizzazione linguistica che consentiva una applicazione più internazionale delle stesse professioni. Ma non solo. Per alcuni diventa occasione per altri percorsi, con un bagaglio tecnico linguistico di prim'ordine.
Non nasconde la sua passione per la Medicina e conseguita la maturità tecnica inizia il suo percorso, lungo e impegnativo, per raggiungere una specializzazione tanto semplice quanto affascinante in ematologia.
Il Curriculum allegato testimonia del suo percorso e della qualità del suo lavoro, anche per i non specialisti.
Birthdate: October 28th, 1973
Birthplace: Torino, Italy
Citizenship: Italian
Address: Divisione Universitaria di Ematologia
Citta’ della salute e della Scienza di Torino
Via Genova 3, 10126 Torino, Italy
Fax: + 39-011-696-3737;
Phone + 39-011-633-6107;
E-mail: luisa.giaccone@unito.it
C.F. GCCLSU73R68L219A
Education and Training:
1992 – 1998 School of Medicine, University of Torino, Italy, M.D. (Graduation July 21, 1998, cum laude)
1999 Italian Board Certification for M.D.
1998 – 2002 Residency and Fellowship in Hematology, University of Torino, Italy. The main interest during the fellowship
was autologous and allogeneic transplant and new drugs (thalidomide) in multiple myeloma, with special focus
on clinical trials. (Graduation December 4, 2002, cum laude)
Jan 2002 – June 2003 Fellow and visiting physician, Clinical Research, Transplantation Biology Department at Fred Hutchinson Cancer Research Center, Seattle and University of Washington, WA, USA. Clinical research on the meaning of plasmatic concentration of mycophenolate mofetil and cyclosporine in allogeneic transplant. Clinical activity in the transplant team (inpatient and outpatient department).
July 2003 – Dec 2003 Fellowship (fondazione Angela Bossolasco), at Hematology Department, University of Torino, Italy:
Tandem autologous-allogeneic transplant in newly diagnosed multiple myeloma. Clinical activity in inpatient and outpatient of the transplantation unit. Clinical trials on nonmieloablative stem cell transplant from related and unrelated donor.
Jan 2004 - May 2004 Fellow and visiting physician, Clinical Research, Transplantation Biology Department at Fred Hutchinson Cancer Research Center, Seattle and University of Washington, WA, USA. Clinical research on the employment of methotrexate in chronic graft versus host disease. Clinical activity in the long term follow-up transplant team (outpatient department).
June 2004 – Aug 2005 Fellowship (Az. Osp. San Giovanni Battista), at Hematology Department, University of Torino, Italy: Nonmyeoablative Allogeneic transplant from unrelated donor in multiple myeloma patients. Clinical activity in inpatient and outpatient of the transplantation unit. Clinical trials on nonmieloablative stem cell transplant from related and unrelated donor.
Sept 2005 – Aug 2006 Fellowship (fondazione Angela Bossolasco), at Hematology Department, University of Torino, Italy: Efficacy and toxicity of nonmyeloablative allogeneic transplant in patients with multiple myeloma at diagnosis and at
relapse. Clinical activity in inpatient and outpatient of the transplantation unit. Clinical trials on nonmieloablative stem cell transplant from related and unrelated donor.
Current Position:
November 1, 2006 – present Assistant Professor at the University of Turin.
Grants:
2012 Ricerca sanitaria finalizzata: ‘Valutazione malattia residua nei pazienti sottoposti a trapianto allogenico per mieloma multiplo
2008 Ricerca sanitaria finalizzata: “Ruolo della lenalidomide come terapia di mantenimento dopo trapianto tandem autologo-allogenico nonmieloablativo nel mieloma multiplo”
2007 Fondi Ex 60%: Immunomodulatory drugs in multiple myeloma as debulky therapy before nonmyeloablative
allogeneic transplantation from HLA identical sibling donors.
2006 Fondi Ex 60%: Use of Bortezomib in multiple myeloma patients with relapsed or progressive disease after allogeneic transplantation